Skip to main content
. 2020 Jan 22;8:e8458. doi: 10.7717/peerj.8458

Figure 6. Nomogram for predicting 3- and 5-year OS and RFS, calibration plot and ROC curve analysis.

Figure 6

(A) Nomogram for predicting ICC patients 3- and 5-year OS integrating lymph node metastasis, CD86+/CD206+ TAMs, tumor multiplicity and CA-199. (B) Nomogram for predicting ICC patients 3- and 5-year RFS integrating lymph node metastasis, CD86+/CD206+ TAMs, tumor multiplicity and CA-199. (C) Calibration plot for predicted and observed 3-year OS. (D) Calibration plot for predicted and observed 5 year OS. (E) Calibration plot for predicted and observed 3 year RFS. (F) Calibration plot for predicted and observed 5 year RFS. (G) ROC curve was performed to further evaluate the OS nomogram and (H) ROC curve was performed to further evaluate the RFS nomogram. OS, Overall survival; RFS, recurrence-free survival; ROC, receiver operating characteristic.

HHS Vulnerability Disclosure